Skip to main content

MoneyWorks4Me

Divi's Laboratories - Quaterly Results

08 Nov 2026 Evaluate
The sales surged to Rs. 36470.00 millions, up 37.11% for the September 2026 quarter as against Rs. 26600.00 millions during the corresponding quarter previous year.Handsome Net Profit growth of 63.79% reported above the corresponding previous quarter figure of Rs. 11400.00 millions to Rs. 6960.00 millions.The company reported a good operating profit of 16750.00 millions compared to 10410.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 36470.00 26600.00 37.11 66210.00 50170.00 31.97 103880.00 91980.00 12.94
Other Income 880.00 1460.00 -39.73 1510.00 2650.00 -43.02 5060.00 3520.00 43.75
PBIDT 16750.00 10410.00 60.90 29780.00 19030.00 56.49 39940.00 33310.00 19.90
Interest 130.00 80.00 62.50 190.00 110.00 72.73 230.00 10.00 2200.00
PBDT 16620.00 10330.00 60.89 29590.00 18920.00 56.40 38970.00 33300.00 17.03
Depreciation 1420.00 1130.00 25.66 2740.00 2250.00 21.78 4610.00 4010.00 14.96
PBT 15200.00 9200.00 65.22 26850.00 16670.00 61.07 34360.00 29290.00 17.31
TAX 3800.00 2240.00 69.64 6540.00 4140.00 57.97 8290.00 7200.00 15.14
Deferred Tax 100.00 40.00 150.00 -60.00 30.00 -300.00 -400.00 -730.00 -45.21
PAT 11400.00 6960.00 63.79 20310.00 12530.00 62.09 26070.00 22090.00 18.02
Equity 530.00 530.00 0.00 530.00 530.00 0.00 530.00 530.00 0.00
PBIDTM(%) 45.93 39.14 17.36 44.98 37.93 18.58 38.45 36.21 6.17
Peers
Company Name CMP
Sun Pharma. Inds. 1915.00
Dr. Reddys Labs. 1378.40
Cipla 1410.00
Lupin 2000.00
Zydus Lifesciences 1200.00
View more..